Sweden

BioLamina secures €20M EIB Financing to accelerate Cell Therapy Innovation
Stockholm-based biotech company BioLamina has secured a €20 million financing commitment from the European Investment Bank (EIB) to scale its technologies supporting next-generation cell therapies.

The best Articles in our Network